Technology is catapulting clinical trials into a 'new era' as scientific breakthroughs bring new opportunities to an industry that has traditionally lacked innovation.
Parexel will dish out $450,000 a year for new Senior VP Ingo Bank, and there's a double recruitment for DPT Laboratories - it's Outsourcing-Pharma.com's People column.
In-Pharmatechnologist.com presents its latest round-up of the movers and shakers in the world of pharmaceuticals, including news from Sanofi and Boehringer Ingelheim.
In-Pharmatechnologist.com presents its latest round-up of the movers and shakers in the world of pharmaceuticals, including news from Sanofi, Bausch + Lomb and BASF.
In-Pharmatechnologist.com presents its latest round-up of the movers and shakers in the world of pharmaceuticals, including news from Onconova, Halozyme and Rib-X Pharmaceuticals.
In-PharmaTechnologist.com presents its latest round-up of the movers and shakers in the world of pharmaceuticals, including news from Merck, BASF and Tenex.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Valeant Pharmaceuticals, Baxter and Achaogen.
in-PharmaTechnologist presents its latest round up movements in the pharma sector, including CytRx bolstering its manufacturing expertise and KV preparing its management as it strives to resume distribution.
in-PharmaTechnologist presents its latest roundup of appointments in the pharmaceutical sector, including movements at UCB Pharma Canada and a resignation at GeoVax.
Outsourcing-Pharma presents its latest round up of movements in the pharmaceutical outsourcing sector, including appointments at WuXi, OctoPlus and Catalent.
In a session chaired by at BIO 2009 John Lechleiter, CEO at Eli Lilly, speakers discussed patent reform, biosimilar bills and why certain options on the table could be a "stake in the heart" of the biotech industry.
Novo Nordisk, Rheosciences, ImClone, Omrix Biopharmaceuticals,
Biogen Idec and Human Genome Sciences, have all had people on the
move in the biotech world.
Some of the world's largest pharma firms have set out what
therapeutic areas and specific mechanisms are becoming more
important to them, and which will be left by the wayside.
BioProgress has appointed Richard Trevillion as chief
executive, bolstering its executive management just over a month
after the dosage film specialist issued a trading statement that
sparked a 40 per cent slump in its UK-listed shares,...
New Year, new job. Busy times for personnel in the pharmaceutical
technology sector, with a series of new appointments.
In-PharmaTechnologist.com provides a round-up.
Bristol-Myers Squibb has announced the sudden death of James
Palmer, aged 51, the firm's chief scientific officer and
president of the Pharmaceutical Research Institute. His death
occurred after undergoing surgery. Elliot Sigal,...
